We have expressed the murine coronavirus haemagglutinin-esterase protein in a vaccinia virus/T7 RNA polymerase system. The levels of expression observed are significantly higher than those found in virusinfected cells. The expressed protein has both receptordestroying (esterase) and receptor-binding (haemadsorption) activities. The use of this system will greatly facilitate analysis of the structure-function relationships of this protein.
Introduction
The coronaviruses are a group of enveloped, positivestrand RNA viruses associated with diseases of economic importance in both animals and humans (Wege et al., 1982) . Among the most intensively studied members of the group are the murine coronaviruses, collectively known as murine hepatitis virus (MHV). These viruses are characterized by their ability to cause a variety of different diseases depending on the virus isolate, the host animal and the route of infection. MHV-based animal models have been established for neurological, enteric and hepatic diseases (Lamontagne et al., 1989; Barthold & Smith, 1989; Perlman et al., 1990) and it is hoped that they will help to elucidate important aspects of viral pathogenesis.
The MHV genome is a 32 kb RNA which encodes four major structural proteins: the nucleocapsid protein, N (50000 to 60000 Mr), the membrane glycoprotein, M (23000 to 26000 Mr), the surface glycoprotein, S (180000 Mr) and the haemagglutinin-esterase glycoprotein, HE (65000 Mr) (Siddell, 1982; Pachuk et aL, 1989) . The sequence of each structural protein gene is known and biological functions have been ascribed to the proteins themselves (for a recent review, see Spaan et al., 1988) . It is reasonable to assume that determinants on each of t Present address: Immuno Research Centre, Uferstrasse 15, 2304 Orth/Donau, Austria.
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The MHV HE gene encodes a polypeptide of 439 amino acids which is N-glycosylated at nine or I0 positions Yokomori et al., 1989) . In the virion, the HE protein is composed of disulphidelinked homodimers of 120000 Mr (Siddell, 1982) . The homodimers are anchored in the virus membrane and form the short spike structures seen in negatively stained preparations (Sugiyama & Amano, 1981) .
As has been noted previously, the predicted amino acid sequence of the MHV HE protein shows about 75 % similarity with the bovine coronavirus (BCV) HE protein and, more remarkably, 30% similarity with the HEF1 subunit of the influenza C virus HEF protein (Luytjes et al., 1988; Parker et al., 1989; Kienzle et al., 1990) . Both the BCV and influenza C virus proteins have haemagglutinin activity and an acetylesterase activity specific for N-acetyl-9-O-acetylneuraminic acid (Herrler et al., 1985; King et al., 1985; Vlasak et al., 1987 Vlasak et al., , 1988a . These activities have been sought in MHV virions, and indeed Yokomori et al. (1989) have shown that the presence of the HE protein in the MHV virion is correlated with the presence of an acetylesterase activity. In contrast, there are conflicting reports of a haemagglutinin activity associated with MHV virions (Sugiyama & Amano, 1980; Walker & Cleator, 1980; Yokomori et al., 1989) .
In the experiments reported here, we have transiently expressed the MHV HE protein at high levels using a recombinant vaccinia virus/T7 RNA polymerase system. This has allowed us to demonstrate directly the functions associated with the MHV HE protein and provides a system to analyse the structure-function relationships of this protein.
Methods
Cells and viruses. HeLa cells (ATCC CCL2), Sac(-) cells (Weiland et al., I978) and DBT cells (Kumanishi, 1967) were grown in monolayers in MEM containing 10% heat-inactivatod foetal calf serum (FCS), glutamine, antibiotics and non-essential amino acids. Sac(-) cells were also grown in suspension culture in modified MEM containing 5 % FCS and antibiotics.
The MHV used in this study was derived from material originally supplied as a suckling mouse brain homogenate, MHV JHM SMB7, by Dr L. Weiner. This material was propagated twice in suckling mouse brain, plaque-purified three times, and then grown for approximately 20 passages at low m.o.i, in Sac(-) cells. This virus population, referred to as MHV JHM in our publications prior to 1986, was used to isolate MHV JHM Wbl, which was plaque-purified twice on DBT cells and amplified by minimal low m.o.i, passage to stocks of approximately 2 × 107 TCIDso per ml. The MHV A59 isolate was obtained from Dr P. Carthew and was plaque-purified twice in DBT cells and amplified as described above to a stock of 2 x 107 TCIDso per ml. MHV virus purification was done as described by Wege et al. (1979) .
The recombinant vaccinia virus, vTF7-3 (Fuerst et al., 1986 ) was plaque-purified and grown to stocks of approximately 2 x 109 p.f.u. per ml in HeLa cells as described by Mackett et al. (1985) . Under the conditions used, this virus does not exhibit haemagglutinin or fusion activities, both non-essential functions for virus replication (Ichihashi & Dales, 1971 ). Influenza C virus (JHB/1/66) was grown in embryonated eggs and purified as described by Herder et al. (1985) .
cDNA cloning and sequence analysis. Poly(A)-containing RNA was isolated from MHV-infected Sac(-) cells as described previously (Siddell et al., 1980) . cDNA synthesis was essentially by the method of Gubler & Hoffman (1983) using the MHV-specific oligonucleotide 5' TTA GAT TAT GCC TCA TGC 3' (complementary to positions 2169 to 2186 in Fig. 1 of Shieh et al., 1989) as a first-strand primer. The synthesized double-stranded cDNAs were treated with T4 DNA polymerase, ligated into SmaI-linearized pBluescript II, KS + DNA and used to transform competent Escherichia coli JM103 cells.
Recombinant clones were identified by colony hybridization with the MHV-specific oligonucleotide 5' AAT ACG ACC GGT AAT GGG 3' (complementary to positions 2070 to 2087 in Fig. 1 of . The cDNA insert of clone 2/C3 was sequenced and found to extend from the primer position to a position 312 nucleotides from the 5' end of the ns2 gene (Schwarz et al., 1990) . The plasmid DNA of the 2/C3 clone was linearized with EcoRV and treated for various times with nuclease Bal 31 [6 ~tg of DNA, 10 units (U) Bal 31, 30 °C, 15 to 90 s]. The truncated DNAs were cut with XbaI, ligated to the XbaI site of XbaI/Smal-cut pBluescript II, KS +, treated with DNA polymerase I (Klenow fragment), self-ligated and used to transform competent E. coli TG1 cells.
Colony hybridizations with two MHV-specific oligonucleotides, 5' ACT GCC CAT TTC AAC AAA AT 3' (complementary to positions 852 to 871 in Fig. 1 of Shieh et al., 1989) and 5' AGT GTA AAA ACA AAT CAA C 3' (complementary to positions 811 to 829 in Fig. 1 of Shieh et al., 1989) were used to identify a clone, pBS +/MHV2-1, which was partially sequenced and contained a cDNA insert extending from seven nucleotides upstream of the HE gene initiation codon to a position three nucleotides downstream of the termination codon.
Finally, the pBS+/MHV2-1 cDNA was excised with XbaI and EcoRI, treated with DNA polymerase I (Klenow fragment) and ligated into the BamHI site of the vaccinia virus transfer vector pTF7-5 (Fuerst et al., 1987) . This construct, pTF7-5/HE, was partially sequenced and contained the complete open reading frame (ORF) of the MHV JHM Wbl HE gene with the initiation codon located 53 nucleotides downstream of the bacteriophage T7 promoter. Plasmid purification, agarose gel electrophoresis and standard recombinant DNA procedures were done as described by Sambrook et al. (1989) . Colony hybridizations were done as described by Woods (1984) .
DNA sequencing was done by the chain termination method (Sanger et al., 1977) . The 2/C3 cDNA insert was sequenced from singlestranded DNA templates after subcloning into M13mp9. The partial sequencing of pBS+/MHV2-1 and pTF7-5/HE was done on doublestranded DNA templates. In all, 17 MHV-specific oligonucleotides, two pBluescript-specific oligonucleotides and the M13 universal primer were used. Sequence data were assembled by the programs of Staden 0982) and analysed with the programs of the University of Wisconsin Genetics Computer Group (Devereux et al., 1984) . Oligonucleotides were synthesized by phosphoramidite chemistry and purified by gel electrophoresis.
Virus infection, labelling and cell lysates. DBT cell monolayers were infected with MHV at an m.o.i, of 6 as previously described (Siddell et al., 1980) . To label intracellular polypeptides, the medium was replaced 12 h after infection for 1 h with medium containing 2~ dialysed FCS and 100 ~tCi of [asS]methionine (S J. 204, 800 Ci/mmol; Amersham Buchler) per ml. To prepare cell lysates, labelled or unlabelled cell monolayers were washed twice with ice cold phosphatebuffered saline (PBS), scraped into PBS and pelleted at 800 g for 2 rain. The cells were then lysed at 4 °C in 50 mM-Tris-HCl pH 7.5, 100 mMNaC1, 0-2% NP40, 500 U of aprotinin per ml (TNPA buffer). The cytoplasmic lysates were centrifuged at 10000 g for 2 rain and the supernatants were stored at -70 °C.
Transient expression. DBT cell monolayers were infected with the vaccinia virus recombinant vTF7-3 (Fuerst et al., 1986) at an m.o.i, of 30 p.f.u./cell. The virus-containing medium was removed 2 h after infection and replaced with 20 p.g of pTF7-5/HE DNA coprecipitated with calcium phosphate as described by Sambrook et al. (1989) . The infected/transfected cells were incubated at 37 °C for 6 h and labelled or unlabeUed cytoplasmic lysates were then prepared as described above. Tunicamycin (2 ~tg/ml) was added to the culture medium after the DNA transfection procedure.
Imrnunoprecipitation and SDS-PAGE.
Cytoplasmic lysates were incubated with two volumes of TNPA buffer containing 1 mg of bovine serum albumin per ml and 1 volume of hybridoma tissue culture supernatant for 2 h at 4 °C. The immunocomplexes were absorbed to a suspension of Protein A-Sepharose and washed three times with TNPA buffer. The complexes were then either resuspended in PBS and assayed for esterase activity (see below), or heated in reducing sample buffer for 5 min at 55 °C. After removal of the Sepharose, the complexes were heated at I00 °C for 2 rain and analysed by SDS-PAGE. The surface glycoprotein-specific monoclonal antibody (MAb) E2-A1 (Wege et al., 1984) and the HE-specific MAb, ct65 (Wege et al., 1987) were kindly provided by H. Wege. SDS-PAGE of lysates and immunoprecipitates was done under reducing conditions on 15% polyacrylamide gels according to the method of Laemmli (1970) .
Esterase and haemadsorption assays. Purified virus or immunocomplexes were resuspended in PBS and incubated with 1 n~-pnitrophenyl acetate at room temperature. Hydrolysis of the substrate was monitored at 405 nm. The inhibition of esterase activity by diisopropyl fluorophosphate (DFP) was assayed by preincubating purified MHV with I mM-DFP in PBS for 30 rain at 4 °C prior to the esterase activity determination. Haemadsorption by DBT cells expressing the MHV HE protein was assayed by incubation with a 2% (v/v) suspension of washed rat erythrocytes in PBS at 4 °C for 30 min, followed by exhaustive washing of the monolayers with ice-cold PBS. 
Results
T h e two m o s t i n t e n s i v e l y studied M H V strains are M H V A 5 9 a n d M H V J H M . Recently, s e q u e n c e analysis (Luytjes et aL, 1988) has s h o w n that the M H V A59 g e n o m e has u n d e r g o n e m u t a t i o n a n d n o longer has a f u n c t i o n a l H E gene. Also, Lai a n d co-workers Fig. 1 (a) shows the esterase activity associated with purified M H V J H M W b l , M H V A59 a n d influenza C virions using a synthetic substrate. As expected, the influenza C virus p r e p a r a t i o n showed a high level of esterase activity, w h i c h is k n o w n to be associated w i t h the surface glycoprotein (Herrler et al., 1988a ). T h e M H V J H M W b l isolate also has a readily detectable esterase activity. In contrast, n o activity a b o v e the level of controls (PBS alone, d a t a n o t shown) could be d e m o n s t r a t e d for the purified M H V A59. In a further experiment, the sensitivity of the MHV JHM-associated esterase activity to the serine esterase inhibitor DFP was assayed. As shown in Fig. 1 (b) , the esterase activity was completely inhibited when the virus was preincubated with t mM-DFP for 30 min. Finally, [3H]DFP was used to confirm that it is indeed the MHV JHM HE protein which is associated with the esterase activity. As can be seen in Fig. 1 (c) and (d), [3H]DFP, which binds covalently to the serine of the esterase active site (Cohen et al., 1967) , labels only the MHV HE protein, either in its reduced monomer form (Fig. 1 d,  lane 1) or as a non-reduced homodimer (Fig. I c, lane I ). , the MAb ~65-HE protein complex from MHV-infected DBT cells (f-q) and the MAb ~65 complex from vTF7-3-infected cells (11) were incubated (in 1 ml) with ln~-p-nitrophenyl acetate and hydrolysis of the synthetic substrate was monitored at 405 nm.
have s h o w n that different M H V J H M isolates e x h i b i t very different levels of H E gene expression. F o r this reason, we decided to c o n f i r m that the M H V J H M W b l isolate does i n d e e d have a f u n c t i o n a l H E gene.
As a control, the binding of [3H]DFP to the reduced and non-reduced forms of the influenza C virus HEF protein ( Fig. 1 d, lane 2 and Fig. 1 c, lane 2) was also demonstrated.
Having confirmed that the MHV JHM Wbl isolate has a functional HE gene, we isolated and sequenced a cDNA copy which contained the complete ORF of this gene. This analysis revealed an ORF of 439 amino acids which encodes a polypeptide of 49000 Mr with 10 potential N-glycosylation sites. The predicted HE protein sequence differs at only three positions (amino acid 133, A to R; amino acid 245, L to F; amino acid 247, C to S) from that determined by Shieh et al. (1989) .
Transient expression of the M H V J H M Wbl H E gene
In order to express the MHV Wbl HE gene in isolation from other viral gene products, it was placed under the control of the bacteriophage T7 promoter and transfected into DBT cells which had previously been infected with the recombinant vaccinia virus vTF7-3. The expression of the HE protein was then monitored by metabolic labelling and immunoprecipitation. Fig. 2  (lanes 5 and 6) shows that in the vaccinia virus/T7 system, the HE protein is dramatically over-expressed when compared to the levels of HE protein expressed during a high multiplicity infection of DBT cells (lanes 2 and 4). The electrophoretic mobility and immunoreactivity of the HE protein expressed in the vaccinia virus/T7 system suggests that it is correctly translated and processed. It is interesting to note that in the presence of tunicamycin (lanes 7 and 8) the amount of HE polypeptide expressed is greatly reduced. The size of the polypeptide synthesized is consistent with the size of the predicted HE apoprotein (approximately 49000 Mr) but apparently, in the absence of cotranslational glycosylation, the polypeptide is either rapidly degraded or poorly translated. It should also be mentioned that in the course of these studies we were unable to isolate a vaccinia virus recombinant which contained an integrated and expressed copy of the M H V H E gene (unpublished data). This may be due to the adverse effects of H E gene expression on vaccinia virus replication.
Functions of the MHV HE protein
Using the vaccinia virus/T7 system, it was possible to analyse directly the biological functions of the M H V HE protein. Firstly, as expected, we were able to show that the HE protein functions as an esterase. The HE proteinMAb complex isolated from DBT cells which had been infected with vTF7-3 and transfected with pTF7-5/HE was clearly able to hydrolyse p-nitrophenyl acetate (Fig.  3) . This activity was not found in cells which had been infected with vTF7-3 but not transfected. In MHV JHM-infected DBT cells, a low level of HE proteinassociated esterase activity was detected, consistent with the low level of HE protein expression illustrated in Fig.  2 .
The second biological function of the HE protein which was investigated was the ability to bind rat erythrocytes. These were chosen because they are known to contain the influenza C virus receptor determinant, Nacetyl-9-O-acetylneuraminic acid in high amounts (Rogers et al., 1986) . As is shown in Fig. 4(c) , DBT cells which expressed the HE protein were able to bind rat erythrocytes at 4 °C. Elevation of the temperature to 37 °C resulted in the subsequent release of these erythrocytes (Fig. 4d) . Uninfected DBT cells or cells infected with the recombinant vaccinia virus vTF7-3 did not have this activity (Fig. 4a and b ). These results demonstrate that the HE protein synthesized in the vaccinia virus/T7 system is transported to the cell surface and they are consistent with the idea that the MHV HE protein has both receptor-binding and receptor-destroying activities.
Discussion
The experiments reported in this paper lead to a number of conclusions. Firstly, they provide the first formal proof that the esterase activity associated with MHV virions is a function of the HE protein. The specificity of this activity has not been determined, but by analogy to the influenza C virus HEF protein, it seems likely that the esterase substrate will be 9-O-acetyl residues on Nacetylneuraminic acid. This idea is supported by the structural analysis of the MHV HE gene which predicts an amino acid stretch, FGDSR (amino acids 42 to 46; Shieh et al., 1989) , identical to the amino acid sequence surrounding the residue which has been identified as the active site serine of the influenza C virus acetylesterase (Herrler et al., 1988b; Vlasak et al., 1989) . Also, the release of bound erythrocytes from HE-expressing cells at 37 °C is consistent with this interpretation.
Secondly, the experiments conclusively demonstrate that the HE protein of MHV JHM has a receptorbinding activity for rat erythrocytes, despite the fact that a haemagglutinin activity associated with the JHM strain of MHV could not be shown . This apparent discrepancy could be explained in two ways. On the one hand, it may be that the level of HE protein expression in the vaccinia virus/T7 system is sufficient to reveal an activity which is normally beyond the sensitivity of the assays employing purified virions. Alternatively, the expression of the HE protein in isolation may unmask the receptor-binding activity. This could be due, for example, to steric hindrance by other virion components.
Thirdly, it is evident that the vaccinia virus/T7 system offers a unique opportunity to analyse the structurefunction relationships of the MHV JHM HE protein. In the heterologous system the level of HE gene expression is significantly higher than in virus-infected cells. This is particularly striking if the efficiency of the transfection and infection procedures is taken into account. We do not know the reason for this over-expression and similar constructs developed to express the MHV S and N proteins in the vaccinia virus/T7 system do not show this property. However, the elevated expression level will greatly facilitate the analysis of the functions associated with HE proteins which have been manipulated, for example, by site-directed mutagenesis.
The final and perhaps most important question arising from these studies is the biological role of the MHV HE protein in the infection process. Clearly, as the MHV A59 isolate does not express an HE protein its functions cannot be essential for replication in transformed murine cells. However, there are at least three lines of evidence which suggest that the HE protein may have an important function in rico. Firstly, MAbs specific for the BCV HE protein are able to neutralize virus infectivity (Deregt & Babiuk, 1987) . Secondly, Taguchi et al. (1986) were able to select MHV JHM isolates which expressed high levels of the HE protein by passage through neural cell cultures. Thirdly, MHV isolates which have not been maintained in tissue culture for prolonged periods of time also express relatively high levels of the HE protein (Sugiyama & Amano, 1980) . Taken together, these data suggest that one or both of the known HE protein functions are relevant to the biological and possibly pathological properties of the virus. Experiments are in progress to investigate the role of the MHV HE protein in the tropism, virulence and cytopathology of murine hepatitis virus infections in vivo.
